Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Mini Review

Published on 02 Apr 2025

The role of NLRP3 inflammasome in multiple sclerosis: pathogenesis and pharmacological application

in Multiple Sclerosis and Neuroimmunology

Wen-Gang Zhang
Xiao-Rui Zheng
Yi Yao
Wei-Jia Sun
Bo-Zong Shao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1572140

2,047 views

Review

Published on 01 Apr 2025

Roles of METTL3 and NLRP3 in pyroptosis and prospects in SCIRI

in Multiple Sclerosis and Neuroimmunology

Xiaoqing Guan
Fengyi Zhang
Ning Zhang
Guangchun Li
Fei Yin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1552704

2,016 views

Mini Review

Published on 25 Mar 2025

Advocating the role of trained immunity in the pathogenesis of ME/CFS: a mini review

in Multiple Sclerosis and Neuroimmunology

Bart Humer
Willem A. Dik
Marjan A. Versnel

Frontiers in Immunology

doi 10.3389/fimmu.2025.1483764

3,615 views

Original Research

Published on 24 Mar 2025

Integrated bioinformatics analysis and biological experiments to identify key immune genes in vascular dementia

in Multiple Sclerosis and Neuroimmunology

Yilong Zhao
Wen Xing
Weiqi Chen
Yilong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1560438

2,641 views

Review

Published on 21 Mar 2025

Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment

in Multiple Sclerosis and Neuroimmunology

Luis Brieva
Carmen Calles
Lamberto Landete
Celia Oreja-Guevara

Frontiers in Immunology

doi 10.3389/fimmu.2025.1543649

3,837 views

Original Research

Published on 14 Mar 2025

Comparison of the clinical and laboratory characteristics of neuromyelitis optica spectrum disorder with or without cerebrospinal fluid oligoclonal bands: a cohort with 36-month follow-up

in Multiple Sclerosis and Neuroimmunology

Wenbo Yang
Xiaoni Liu
Jie Wei
Hai Yu
Wanqing Wu
Jingguo Wang
Bo Deng
Xiaoqin Wu
Xiangjun Chen
Xiang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1536853

1,536 views

Case Report

Published on 14 Mar 2025

Case Report: CASPR2-associated autoimmune encephalitis with NF155 Antibody-positive autoimmune nodopathies: a rare case with hyponatremia onset

in Multiple Sclerosis and Neuroimmunology

Wen-Ya Wang
Jing-Ying Huang
Ying Xue
An-Ran Zhang
Ruo-Yi Guo
Zhen Jia
Ya-Fei Sun
Bin Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519878

1,128 views

Case Report

Published on 11 Mar 2025

Case Report: Ofatumumab treatment for concomitant multiple sclerosis and idiopathic thrombocytopenic purpura

in Multiple Sclerosis and Neuroimmunology

Yuki Yokota
Makoto Hara
Hideto Nakajima

Frontiers in Immunology

doi 10.3389/fimmu.2025.1515776

2,683 views

Original Research

Published on 05 Mar 2025

Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Mustafa Sindi
Michael Dietrich
Diana Klees
Joel Gruchot
Christina Hecker
John Silbereis
Andrea Issberner
Hans-Peter Hartung
Tobias Ruck
Holger Stark

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532877

2,184 views

Correction

Published on 05 Mar 2025

Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

in Multiple Sclerosis and Neuroimmunology

Heinz Wiendl
Frederik Barkhof
Xavier Montalban
Anat Achiron
Tobias Derfuss
Andrew Chan
Suzanne Hodgkinson
Alexandre Prat
Letizia Leocani
Klaus Schmierer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1571978

1,236 views

Original Research

Published on 03 Mar 2025

The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study

in Multiple Sclerosis and Neuroimmunology

Jiafei Cheng
Zhuoran Wang
Jing Wang
Xiaomin Pang
Jianli Wang
Meini Zhang
Junhong Guo
Huaxing Meng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1527057

2,110 views
1 citation

Review

Published on 28 Feb 2025

Digital remote monitoring of people with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Michelangelo Dini
Giancarlo Comi
Letizia Leocani

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514813

3,093 views

Original Research

Published on 27 Feb 2025

The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study

in Multiple Sclerosis and Neuroimmunology

Jeske van Pamelen
Carla Rodriguez-Mogeda
Lynn van Olst
Susanne M. A. van der Pol
Maarten L. Boon
Janet de Beukelaar
Oliver H. H. Gerlach
Andries E. Budding
Joep Killestein
Helga E. de Vries

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514762

2,687 views

Case Report

Published on 25 Feb 2025

Case Report: Long-term suppression of relapses by dimethyl fumarate in a relapsing pediatric patient with myelin oligodendrocyte glycoprotein antibody–associated disease manifesting as acute disseminated encephalomyelitis, unilateral optic neuritis, and seizure episodes

in Multiple Sclerosis and Neuroimmunology

Masayuki Tahara
Tomonari Awaya
Keisuke Saito
Hideyuki Sawada

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551379

1,780 views

Case Report

Published on 24 Feb 2025

Case Report: MOGAD - a steroid-responsive autoimmune meningoencephalitis mimicking infection

in Multiple Sclerosis and Neuroimmunology

Yihui Goh
Priscillia Pei Shi Lye
Paul Anantharajah Tambyah
Derek Tuck Loong Soon
Nares Smitasin
Jonathan Jia Yuan Ong
Clement Hsiang Rong Yong
Yee Cheun Chan
David Tang
Kay Wei Ping Ng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516178

1,980 views
1 citation

Original Research

Published on 24 Feb 2025

The changes of NLRs family members in the brain of AD mouse model and AD patients

in Multiple Sclerosis and Neuroimmunology

Zehan Li
Yanling He
Jingdan Zhang
Jing Yang
Jinbo Cheng
Xuewu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555124

2,317 views